572 related articles for article (PubMed ID: 19914792)
1. Possible involvement of PKC-delta in the abrogated cardioprotective potential of ischemic preconditioning in hyperhomocysteinemic rat hearts.
Rohilla A; Singh G; Singh M; Bala kumar P
Biomed Pharmacother; 2010 Mar; 64(3):195-202. PubMed ID: 19914792
[TBL] [Abstract][Full Text] [Related]
2. Modulation of cardioprotective effect of ischemic pre- and postconditioning in the hyperhomocysteinemic rat heart.
Balakumar P; Rohilla A; Singh G; Singh K; Singh M
Methods Find Exp Clin Pharmacol; 2009 Mar; 31(2):71-9. PubMed ID: 19455261
[TBL] [Abstract][Full Text] [Related]
3. The infarct size-limiting effect of ischemic postconditioning (IPOC) is suppressed in isolated hyperhomocysteinemic (Hhcy) rat hearts: the reasonable role of PKC-delta.
Rohilla A; Balakumar P
Biomed Pharmacother; 2009 Dec; 63(10):787-91. PubMed ID: 19914793
[TBL] [Abstract][Full Text] [Related]
4. Adenosine-A1 receptors activation restores the suppressed cardioprotective effects of ischemic preconditioning in hyperhomocysteinemic rat hearts.
Balakumar P; Singh H; Reddy K; Anand-Srivastava MB
J Cardiovasc Pharmacol; 2009 Sep; 54(3):204-12. PubMed ID: 19568176
[TBL] [Abstract][Full Text] [Related]
5. Possible role of JAK-2 in attenuated cardioprotective effect of ischemic preconditioning in hyperhomocysteinemic rat hearts.
Singh G; Rohilla A; Singh M; Balakumar P
Yakugaku Zasshi; 2009 May; 129(5):523-35. PubMed ID: 19420883
[TBL] [Abstract][Full Text] [Related]
6. A comparative study on the cardioprotective potential of atorvastatin and simvastatin in hyperhomocysteinemic rat hearts.
Rohilla A; Ahmad A; Khan MU; Khanam R
Eur J Pharmacol; 2015 Oct; 764():48-54. PubMed ID: 26130125
[TBL] [Abstract][Full Text] [Related]
7. Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning.
Serejo FC; Rodrigues LF; da Silva Tavares KC; de Carvalho AC; Nascimento JH
J Cardiovasc Pharmacol; 2007 Apr; 49(4):214-20. PubMed ID: 17438406
[TBL] [Abstract][Full Text] [Related]
8. Additive protection of the ischemic heart ex vivo by combined treatment with delta-protein kinase C inhibitor and epsilon-protein kinase C activator.
Inagaki K; Hahn HS; Dorn GW; Mochly-Rosen D
Circulation; 2003 Aug; 108(7):869-75. PubMed ID: 12860903
[TBL] [Abstract][Full Text] [Related]
9. [Effects of ischemia postconditioning on ischemia-reperfusion injury and reperfusion injury salvage kinase signal transduction pathways in isolated mouse hearts].
Zhang JF; Ma YT; Yang YN; Gao XM; Liu F; Chen BD; Li XM; Xiang Y
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Feb; 36(2):161-6. PubMed ID: 19099957
[TBL] [Abstract][Full Text] [Related]
10. Activation of protein kinase C delta reduces hepatocellular damage in ischemic preconditioned rat liver.
Yun N; Lee SM
J Surg Res; 2013 Dec; 185(2):869-76. PubMed ID: 23932656
[TBL] [Abstract][Full Text] [Related]
11. Possible involvement of erythropoietin in remote renal preconditioning-induced cardioprotection in rats.
Diwan V; Jaggi AS; Singh M; Singh N; Singh D
J Cardiovasc Pharmacol; 2008 Feb; 51(2):126-30. PubMed ID: 18287879
[TBL] [Abstract][Full Text] [Related]
12. Ischemic preconditioning in immature hearts: mechanism and compatibility with cardioplegia.
Zhu B; Min S; Long C; Ye T
Chin Med J (Engl); 2003 Feb; 116(2):253-7. PubMed ID: 12775242
[TBL] [Abstract][Full Text] [Related]
13. The role of C-reactive protein in ischemia/reperfusion injury and preconditioning in a rat model of myocardial infarction.
Valtchanova-Matchouganska A; Gondwe M; Nadar A
Life Sci; 2004 Jul; 75(8):901-10. PubMed ID: 15193950
[TBL] [Abstract][Full Text] [Related]
14. Cardioprotective potential of simvastatin in the hyperhomocysteinemic rat heart.
Rohilla A; Khan MU; Khanam R
J Adv Pharm Technol Res; 2012 Jul; 3(3):193-8. PubMed ID: 23057007
[TBL] [Abstract][Full Text] [Related]
15. Adenosine transport blockade restores attenuated cardioprotective effects of adenosine preconditioning in the isolated diabetic rat heart: potential crosstalk with opioid receptors.
Sharma NK; Mahadevan N; Balakumar P
Cardiovasc Toxicol; 2013 Mar; 13(1):22-32. PubMed ID: 22948709
[TBL] [Abstract][Full Text] [Related]
16. Modulation of the cardioprotective effect of ischemic preconditioning in hyperlipidaemic rat heart.
Yadav HN; Singh M; Sharma PL
Eur J Pharmacol; 2010 Sep; 643(1):78-83. PubMed ID: 20598682
[TBL] [Abstract][Full Text] [Related]
17. Myocardial protection with postconditioning is not enhanced by ischemic preconditioning.
Halkos ME; Kerendi F; Corvera JS; Wang NP; Kin H; Payne CS; Sun HY; Guyton RA; Vinten-Johansen J; Zhao ZQ
Ann Thorac Surg; 2004 Sep; 78(3):961-9; discussion 969. PubMed ID: 15337028
[TBL] [Abstract][Full Text] [Related]
18. The possible role of adrenergic component in ischemic preconditioning.
Sharma A; Singh M
Methods Find Exp Clin Pharmacol; 1997 Sep; 19(7):493-9. PubMed ID: 9413833
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial K(ATP) channel as an end effector of cardioprotection during late preconditioning: triggering role of nitric oxide.
Wang Y; Kudo M; Xu M; Ayub A; Ashraf M
J Mol Cell Cardiol; 2001 Nov; 33(11):2037-46. PubMed ID: 11708847
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia.
Lu K; Otani H; Yamamura T; Nakao Y; Hattori R; Ninomiya H; Osako M; Imamura H
J Thorac Cardiovasc Surg; 2001 Jan; 121(1):137-48. PubMed ID: 11135170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
